UK markets closed
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
82.51 -0.18 (-0.22%) GOLD FUTURES
2,394.40 +6.00 (+0.25%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
51,155.08 +2,033.58 (+4.14%)
CorMedix, Inc. (CRMD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 299.10M |
| Enterprise value | 223.73M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.68k |
| Price/book (mrq) | 4.26 |
| Enterprise value/revenue | 3.79k |
| Enterprise value/EBITDA | -4.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.89 |
| 52-week change 3 | 15.25% |
| S&P500 52-week change 3 | 21.61% |
| 52-week high 3 | 7.00 |
| 52-week low 3 | 2.57 |
| 50-day moving average 3 | 3.93 |
| 200-day moving average 3 | 3.72 |
Share statistics
| Avg vol (3-month) 3 | 559.43k |
| Avg vol (10-day) 3 | 1.2M |
| Shares outstanding 5 | 54.98M |
| Implied shares outstanding 6 | 54.98M |
| Float 8 | 54.43M |
| % held by insiders 1 | 1.01% |
| % held by institutions 1 | 34.12% |
| Shares short (28 Mar 2024) 4 | 8.25M |
| Short ratio (28 Mar 2024) 4 | 15.92 |
| Short % of float (28 Mar 2024) 4 | 15.00% |
| Short % of shares outstanding (28 Mar 2024) 4 | 15.00% |
| Shares short (prior month 29 Feb 2024) 4 | 7.72M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 26 Mar 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 26 Mar 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -42.47% |
| Return on equity (ttm) | -74.02% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -48.89M |
| Net income avi to common (ttm) | -46.34M |
| Diluted EPS (ttm) | -0.91 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 76.03M |
| Total cash per share (mrq) | 1.38 |
| Total debt (mrq) | 667.63k |
| Total debt/equity (mrq) | 0.95% |
| Current ratio (mrq) | 6.97 |
| Book value per share (mrq) | 1.28 |
Cash flow statement
| Operating cash flow (ttm) | -38.41M |
| Levered free cash flow (ttm) | -22.97M |
© 2024 Yahoo. All rights reserved.